Halozyme Therapeutics Insider Sold Shares Worth $6,610,501, According to a Recent SEC Filing

MT newswire2026/10/09 07:42

03:42 AM EDT, 10/09/2026 (MT Newswires) -- Helen Torley, Director, President and Chief Executive Officer, on October 06, 2026, sold 60,000 shares in Halozyme Therapeutics (HALO) for $6,610,501. Following the Form 4 filing with the SEC, Torley has control over a total of 767,780 common shares of the company, with 767,780 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1159036/000115903626000140/xslF345X05/wk-form4_1791503775.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Retail investors return to AI! Citadel Securities: net buying of US stocks reached $9.1 billions last week, third highest chip stock purchases in a year

Retail investors, who once hesitated, are now returning to their favorite bet: artificial intelligence (AI).

智通财经•2026/10/13 22:51

HII wins $56 million US Navy contract for AUKUS submarine design support

Bitget•2026/10/13 22:21

Updated version: Zealand Pharma reaches an AI weight-loss drug deal with Generate valued at up to 1.2 billions USD.

路透社•2026/10/13 22:17

Chinese Yuan: Outlook stays mildly positive against US Dollar – UOB

FXStreet•2026/10/13 21:18